Burkholderia cenocepacia bacteremia in the oncology clinic: clinical features and outcomes

Burkholderia cenocepacia bacteremia in the oncology clinic: clinical features and outcomes

Aim of the study: To determine clinical course of Burkholderia cenocepacia bacteremia and outcomes in patients receiving cancer therapy. Materials and methods: We indentified 10 adult patients with culture-verified catheter-related Burkholderia cenocepacia bacteremia. Pathogens were identified with...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. A. Kurmukov, A. M. Pronina, Sh. R. Kashiya, N. S. Bagirova, N. V. Dmitrieva, Z. V. Grigor’yevskaya, I. N. Petuhova, I. V. Tereshchenko
Format:	Article
Language:	Russian
Published:	Journal Infectology 2019-05-01
Series:	Журнал инфектологии
Subjects:	burkholderia cenocepacia bloodstream infection hospital epidemiology nosocomial infection antimicrobial resistance totally implantable venous access port
Online Access:	https://journal.niidi.ru/jofin/article/view/890
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multi-target combination of antibiotics as salvage therapy for severe infection caused by pan-resistant Burkholderia cenocepacia following lung transplantation
by: Nadim Cassir, et al.
Published: (2025-02-01)

Unravelling resistance in Burkholderia cenocepacia: Multi-omic insights into genetic and transcriptomic adaptations to sub-inhibitory antibiotic stress
by: Himanshu Joshi, et al.
Published: (2024-12-01)

Macrophages as drivers of an opportunistic infection
by: Annette C. Vergunst, et al.
Published: (2017-09-01)

Unraveling Burkholderia cenocepacia H111 fitness determinants using two animal models
by: Sarah Paszti, et al.
Published: (2025-04-01)

Burkholderia cepacia complex bacteremia outbreaks among non-cystic fibrosis patients in the pediatric unit of a university hospital
by: Sinan Tüfekci, et al.
Published: (2021-04-01)

Problems of in vitro Antibiotic Susceptibility Compliance with Efficacy of Chemotherapy in Infections Due to Pathogenic Burkholderias
by: V. I. Ilyukhin, et al.
Published: (2020-05-01)

Bacteremia caused by Aeromonas species in patients with cancer: Clinical manifestations and outcomes
by: Cynthia Pamela Alatorre-Fernández, et al.
Published: (2023-03-01)

Diabetic foot osteomyelitis caused by Burkholderia pseudomallei: first case report from Türkiye and a review of literature
by: Cumhur Özmen, et al.
Published: (2025-06-01)

Bacteremia in the Gulf Cooperation Council Region: A Review of the Literature 2013&ndash;2023
by: Al-Musawi T, et al.
Published: (2025-05-01)

An Intensive Care Outbreak Caused by <i>Burkholderia cepacia</i> from Bacterial Filters
by: Özlem Aytaç, et al.
Published: (2025-03-01)

Pulmonary microbial spectrum of Burkholderia multivorans infection identified by metagenomic sequencing
by: Hui Xu, et al.
Published: (2025-06-01)

COMPARISON OF THE CLINICAL ACTIVITY OF TWO OXAZOLIDINONES – LINEZOLID AND TEDIZOLIDE: UNJUSTIFIED EXPECTATIONS
by: N. V. Dmitrieva, et al.
Published: (2018-11-01)

In vitro susceptibility of Burkholderia cepacia to ceftazidime-avibactam: A systematic review
by: Abolfazl Rafati Zomorodi, et al.
Published: (2025-08-01)

INFECTIOUS ENDOCARDITIS CAUSED BY A RARE AGENT BURKHOLDERIA CEPACIAN
by: N. S. Chipigina, et al.
Published: (2018-08-01)

Dual RNA-seq reveals a type 6 secretion system-dependent blockage of TNF-α signaling and BicA as a Burkholderia pseudomallei virulence factor important during gastrointestinal infection
by: Javier I. Sanchez-Villamil, et al.
Published: (2022-12-01)

The High mortality and antimicrobial resistance of Klebsiella pneumoniae bacteremia in northern Taiwan
by: Chyi-Liang Chen, et al.
Published: (2020-04-01)

Interferon-gamma-activated macrophages infected with Burkholderia cenocepacia process and present bacterial antigens to T-cells by class I and II major histocompatibility complex molecules
by: Roberto Rosales-Reyes, et al.
Published: (2020-01-01)

Impact of rapid antibiotic susceptibility testing for Gram-negative bacteremia varies by pathogen type and resistance: a secondary analysis of the RAPIDS GN trial
by: Ritu Banerjee, et al.
Published: (2025-02-01)

Cervical osteomyelitis caused by Burkholderia cepacia after rhinoplasty
by: Lenny Weinstein, et al.
Published: (2008-02-01)

Emergence of ceftazidime resistance in Burkholderia pseudomallei during therapy: Clinical, phenotypic and genotypic insights from paired isolates
by: Pintip Suchartlikitwong, et al.
Published: (2025-06-01)

Antimicrobial Lock Therapy: A Strategy for Managing Catheter-Related Bacteremia
by: Firdevs Aksoy, et al.
Published: (2025-04-01)

TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY
by: Rola Husni, et al.
Published: (2021-04-01)

Neurologic melioidosis presented as encephalomyelitis and subdural collection in two male labourers in India
by: Kavitha Saravu, et al.
Published: (2015-11-01)

Fatal Acute Hypoxemic Respiratory Failure Caused by Burkholderia thailandensis, China
by: Pei Zhang, et al.
Published: (2025-07-01)

Red blood cell distribution width to albumin ratio as a predictor of mortality in ICU patients with community acquired bacteremia
by: Xiaoxi Shan, et al.
Published: (2024-11-01)

Impact of rapid blood culture identification PCR panel on optimal antibiotic use in methicillin-susceptible Staphylococcus aureus bacteremia
by: Jahnavi Yetukuri, et al.
Published: (2024-12-01)

A flagella-dependent Burkholderia jumbo phage controls rice seedling rot and steers Burkholderia glumae toward reduced virulence in rice seedlings
by: Brittany S. I. Supina, et al.
Published: (2025-03-01)

Bloodstream infections epidemiology and clinical outcomes after 1 year post allogeneic hematogenous stem cell transplantation
by: Silvia Corcione, et al.
Published: (2025-08-01)

Clinical characteristics associated with peripartum maternal bloodstream infection
by: Xiao-Li Gao, et al.
Published: (2024-11-01)

Nosocomial Burkholderia cepacia infections in a Turkish university hospital: a five-year surveillance
by: Murat Dizbay, et al.
Published: (2009-05-01)

An integrated approach to the diagnosis of bacterial and fungal bloodstream infections in cancer patients
by: O. Yu. Kutsevalova, et al.
Published: (2020-11-01)

Effectiveness of a novel selective medium ‘Modified MacConkey Agar for Burkholderia’ for isolation of Burkholderia pseudomallei from contaminated specimen
by: Aunta Melan, et al.
Published: (2025-09-01)

Melioidosis in an infant presenting with Eschar-like lesion: A Diagnostic Dilemma
by: Pragathesh Palaniappan, et al.
Published: (2025-07-01)

Comparison of homologous and heterologous vaccination strategies for combating disease caused by Burkholderia pseudomallei
by: Sergei S. Biryukov, et al.
Published: (2025-06-01)

Clinical features and risk factors of older adults with bloodstream infection
by: Mengxi Ding, et al.
Published: (2025-05-01)

Clinical Prediction of Secondary Bloodstream Infections in Patients with Cerebral Infarction: A Nomogram-Driven Risk Assessment Model Based on LASSO Regression
by: Zhang L, et al.
Published: (2025-07-01)

Genomic dataset of eighteen Burkholderia pseudomallei strains isolated from clinical and environmental settings in Malaysia
by: Noreafifah Semail, et al.
Published: (2025-01-01)

Adherence to <i>Staphylococcus aureus</i> Bacteremia Management Recommendations Before, During, and After the COVID-19 Pandemic: Prognostic Implications
by: Elizabeth Lorenzo-Hernández, et al.
Published: (2025-06-01)

Antibody and serum bactericidal response to Burkholderia pseudomallei in acute localized and septicemic melioidosis cases with diabetes mellitus
by: Sraboni Mazumder, et al.
Published: (2025-01-01)

HOSPITAL-ACQUIRED URINARY TRACT INFECTIONS IN CANCER PATIENTS
by: N. V. Dmitrieva, et al.
Published: (2017-12-01)